YEL068C Antibody is a polyclonal antibody targeting the YEL068C protein encoded by the YEL068C gene in Saccharomyces cerevisiae (Baker’s yeast). This antibody is validated for use in research applications such as immunoblotting, immunofluorescence, and chromatin immunoprecipitation (ChIP) to study protein localization, interactions, and genomic stability mechanisms .
YEL068C Antibody is primarily employed in studies investigating:
Genomic Instability: The YEL068c locus is used as a marker in gross chromosomal rearrangement (GCR) assays to quantify mutation rates and DNA repair efficiency .
Replication Stress: This antibody aids in detecting protein interactions involved in DNA replication fork progression and checkpoint activation .
Epigenetic Regulation: YEL068C’s role in chromatin organization and transcriptional silencing has been explored using ChIP assays .
Studies using YEL068C Antibody revealed that deletion of YEL068C increases GCR rates by 10–20 fold in yeast, highlighting its role in maintaining genomic stability . This aligns with its interaction with replication stress sensors like Rad53 and Ddc1 .
Mutation Rate Analysis: In GCR assays, loss of the URA3 and CAN1 markers at the YEL068c locus is quantified using selective media (e.g., 5-FOA + canavanine) . The formula for calculating GCR rates is:
Here, = mutational events, = colonies on selective media, and = total colonies .
Protein Interactions: Co-immunoprecipitation experiments with YEL068C Antibody identified its association with replication machinery components, including Pol2 and Mrc1 .
Specificity: Validated using S. cerevisiae lysates in Western blotting, showing a single band at the predicted molecular weight (~45 kDa) .
Cross-Reactivity: No observed reactivity with human or bacterial proteins .
While YEL068C Antibody is specific to yeast, analogous antibodies targeting human homologs (e.g., BRAF V600E monoclonal antibodies) demonstrate the broader utility of epitope-specific reagents in translational research .
Current limitations include restricted species reactivity and a lack of commercial conjugates (e.g., fluorescent tags). Future studies could explore engineered variants for live-cell imaging or high-throughput screening.
YEL068C is a genetic locus in Saccharomyces cerevisiae (baker's yeast) that has been used as an insertion site for experimental cassettes in genomic instability research. The URA3-CAN1 cassette is frequently inserted at this locus for gross chromosomal rearrangement (GCR) assays, making it an important site for studying DNA replication and repair mechanisms . Antibodies targeting proteins expressed from or associated with this locus would be valuable for researchers investigating replication dynamics and genomic stability.
When selecting a YEL068C antibody, consider the specific experimental application (Western blot, immunoprecipitation, immunofluorescence), the host species, and validation data availability. As with other yeast protein antibodies, refer to antibody data repositories that share validation data for specific applications . For yeast proteins like those associated with YEL068C, check whether the antibody has been validated in wild-type versus knockout strains to confirm specificity. Additionally, review the clonality (monoclonal versus polyclonal) based on your experimental needs for specificity versus epitope coverage.
Essential controls include:
Negative control: YEL068C deletion strain lysates to confirm antibody specificity
Loading control: Anti-β-tubulin antibody (similar to what's mentioned in search result )
Technical controls: Secondary antibody-only samples to assess non-specific binding
Positive control: If studying in the context of DNA replication, include controls for known replication factors (like those in the CMG complex mentioned in the search results)
Based on standard protocols for yeast proteins:
Extract proteins using bead-beating in an appropriate lysis buffer (similar to the one described in search result : "50 mM HEPES-KOH pH 7.5, 140 mM sodium chloride, 1% Triton X-100, 2 mM magnesium chloride, with protease inhibitors")
Separate proteins by SDS-PAGE and transfer to nitrocellulose membrane
Block with 5% BSA or non-fat milk in TBST
Incubate with primary YEL068C antibody (typically 1:1000 dilution) overnight at 4°C
Wash with TBST (3-5 times for 5 minutes each)
Incubate with appropriate secondary antibody (1:5000-1:10000) for 1 hour at room temperature
Wash and develop using chemiluminescent detection
This approach is consistent with the Western blotting procedures described for other yeast proteins in the search results .
For optimal co-immunoprecipitation results:
Lyse cells in a buffer that preserves protein-protein interactions while effectively extracting proteins of interest (reference the co-IP buffer from search result )
Pre-clear lysate with Protein G beads to reduce non-specific binding
Incubate cleared lysate with YEL068C antibody (approximately 2-5 μg per 1 mg of protein) for 3 hours at 4°C
Add fresh Protein G beads and incubate for an additional 1 hour
Wash beads thoroughly (4-5 times) with lysis buffer containing reduced detergent
Elute bound proteins with 2× Laemmli buffer without DTT as described in the methods
Analyze by Western blotting with antibodies against suspected interaction partners
To investigate YEL068C in relation to DNA replication:
Synchronize yeast cells in G1 phase using alpha-factor (5 μg/ml) until >90% arrest is achieved
Release cells into S phase by washing and resuspending in fresh medium
Collect samples at various time points (e.g., 0, 20, 40, 60, and 80 minutes post-release)
Process samples for flow cytometry to track S phase progression
In parallel, prepare protein extracts for Western blotting with YEL068C antibody
Consider performing 2D gel electrophoresis to analyze replication intermediates at origins like ARS305 and ARS1212
Use co-immunoprecipitation to assess interactions with replication factors such as components of the CMG complex
This experimental design follows approaches used for studying replication factors in yeast as described in the search results .
For investigating genomic instability:
Establish strains with the URA3-CAN1 cassette inserted at YEL068C as described in search result
Perform Gross Chromosomal Rearrangement (GCR) assays by plating cells on SC + 5-FOA + canavanine (FC) and YPD plates
Calculate GCR rates using the formula: m/NT, where m(1.24 + ln[m]) - NFC = 0
In parallel, use YEL068C antibody to track protein expression and modification status during genomic instability events
Combine with chromatin immunoprecipitation (ChIP) to identify genomic binding sites
Correlate protein levels or modifications with mutation rates to establish functional relationships
To analyze protein-DNA interactions:
Perform electrophoretic mobility shift assays (EMSA) with purified protein and labeled DNA substrates
Titrate protein concentration (e.g., 1, 2, 5, 7.5, and 10 nM) against a fixed DNA concentration (e.g., 25 nM)
Conduct binding reactions in appropriate buffer (e.g., "20 mM HEPES (pH 7.6), 10% glycerol, 2 mM EDTA, 2 mM DTT, 0.2 mg ml^-1 BSA, and 0.02% NP-40")
Resolve protein-DNA complexes by native polyacrylamide gel electrophoresis
Quantify using fluorescence imaging systems
Compare binding affinities and patterns between wild-type and mutant proteins to assess functional significance
For comprehensive replication fork studies:
Use two-dimensional agarose gel electrophoresis to analyze replication intermediates
Compare patterns of bubble-shaped and Y-shaped intermediates at early and late origins
Quantify the percentage of different replication intermediate structures
In parallel, use YEL068C antibody for Western blotting and ChIP analysis at different time points during S phase
Compare replication patterns between wild-type and mutant strains
Correlate protein localization data with replication fork progression or stalling events
Assess the impact of replication stress (e.g., hydroxyurea treatment) on protein dynamics
Several factors can contribute to inconsistent signals:
Protein extraction efficiency: Ensure consistent cell lysis by standardizing bead-beating time and buffer composition
Protein degradation: Add complete protease inhibitor cocktail to all buffers (e.g., "1× protease inhibitor cocktail (APExBIO, Cat. # K1009)")
Transfer efficiency: Validate transfer by using stained protein ladders and Ponceau S staining
Antibody quality: Aliquot antibodies to avoid freeze-thaw cycles and store at recommended temperatures
Detection sensitivity: Optimize exposure times and consider using more sensitive detection methods for low-abundance proteins
When facing contradictory results:
Verify antibody specificity using knockout controls
Consider post-translational modifications that might affect epitope recognition
Assess whether the protein might be functioning in a complex where epitopes are masked
Evaluate the possibility of alternative splicing or processing affecting the detected protein species
Design experiments to test specific hypotheses about the contradiction, such as:
Does the protein level correlate with activity?
Are there compensatory mechanisms at play?
Could the timing of protein expression versus genetic effects explain the discrepancy?
For rigorous quantitative analysis:
Include a standard curve of recombinant protein or serial dilutions of a reference sample
Use appropriate loading controls (e.g., β-Tubulin as mentioned in search result )
Capture images within the linear range of detection
Normalize YEL068C signal to loading control signal using densitometry software
Perform statistical analysis across biological replicates (minimum of three)
Consider using mass spectrometry-based approaches for absolute quantification
For time-course experiments, express data as fold-change relative to time zero or appropriate reference point
| Method | Sensitivity | Specificity | Quantification | Spatial Information | Technical Complexity |
|---|---|---|---|---|---|
| Western Blot | Medium | High | Semi-quantitative | None | Moderate |
| Immunoprecipitation | High | Medium-High | Low | None | High |
| ChIP | Medium | Medium-High | Semi-quantitative | Genomic location | High |
| Immunofluorescence | Low-Medium | Variable | Low | Subcellular localization | Moderate |
| Mass Spectrometry | High | Very High | Quantitative | None | Very High |
For comprehensive antibody validation:
Test antibody with positive and negative controls (wild-type vs. deletion strains)
Perform peptide competition assays to confirm epitope specificity
Compare results across different applications (Western blot, IP, IF)
Validate against tagged versions of the protein if available
Consider cross-validation with multiple antibodies targeting different epitopes
Document all validation data according to antibody reporting standards
Submit validation data to antibody repositories to benefit the research community
| Cell Cycle Phase | Expected Protein Level | Potential Modifications | Typical Cellular Localization | Functional Significance |
|---|---|---|---|---|
| G1 | Baseline | Minimal phosphorylation | Primarily nuclear | Preparation for replication |
| S | Elevated | Increased phosphorylation | At replication forks | Active in DNA synthesis |
| G2 | Decreasing | Dephosphorylation beginning | Diffuse nuclear | Post-replication roles |
| M | Low | Possibly ubiquitinated | Excluded from condensed chromatin | Regulatory turnover |
This interpretation framework is based on the cell cycle analysis protocols and replication protein dynamics described in search result .
When studying replication stress responses:
Monitor both total protein levels and post-translational modifications
Track changes in protein-protein interactions, particularly with checkpoint proteins like Rad53
Assess chromatin association patterns before and after stress induction
Compare wild-type responses to those in checkpoint-deficient backgrounds
Evaluate correlation between YEL068C protein dynamics and replication fork progression
Consider the timing of events in relation to checkpoint activation
Analyze potential colocalization with markers of stalled replication forks